Morrison Laurie J, Verbeek P Richard, Vermeulen Marian J, Kiss Alex, Allan Katherine S, Nesbitt Lisa, Stiell Ian
Prehospital and Transport Medicine Research Program, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5 Canada.
Resuscitation. 2007 Aug;74(2):266-75. doi: 10.1016/j.resuscitation.2007.01.009. Epub 2007 Mar 23.
The primary aim was to derive a new termination of resuscitation (TOR) clinical prediction rule for advanced life support paramedics (ALS) and to measure both its pronouncement rate and diagnostic test characteristics. Secondary aims included measuring the test characteristics of a previously derived and published basic life support termination of resuscitation (BLS TOR) clinical prediction rule [Morrison LJ, Visentin LM, Kiss A, et al. Validation of a rule for termination of resuscitation in out-of-hospital cardiac arrest. N Engl J Med 2006;355(5):478-87] on the same cohort of patients for comparison purposes.
Secondary data analysis of adult cardiac arrests treated by ALS in rural and urban EMS systems participating in the OPALS study (data extracted from Phase III). A previous study for a basic life support termination of resuscitation (BLS TOR) clinical prediction rule proposed Termination of Resuscitation if the patient had no return of spontaneous circulation (ROSC) before transport; no shock administered; EMS personnel did not witness the arrest [Morrison LJ, Visentin LM, Kiss A, et al. Validation of a rule for termination of resuscitation in out-of-hospital cardiac arrest. N Engl J Med 2006;355(5):478-87]. Multivariable logistic regression was used to examine the relationship between these variables, additional Utstein variables, and the primary outcome of survival to hospital discharge. Diagnostic test characteristics were measured for both the ALS TOR and BLS TOR models on this derivation cohort.
Four thousand six hundred and seventy-three cardiac arrest patients were included; 3098 (66%) were male, mean (S.D.) age 69 (15); 239 (5.1%; 95% CI 4.5-5.8) survived to hospital discharge; 3841 patients had no ROSC (82%) and of these only three survived (0.08%; 95% CI 0.02, 0.23). The final ALS TOR model associated with survival, included: ROSC (OR 260.9; 95% CI 96.3, 706.7), bystander witnessed (OR 2.0; 95% CI 1.3, 3.1), bystander CPR (OR 2.8; 95% CI 1.9, 4.1), EMS witnessed (OR 12.3; 95% CI 7.1, 21.3) and shock prior to transport (OR 6.4; 95% CI 4.1, 10.1). A new ALS TOR clinical prediction rule based on these variables was 100% sensitive (95% CI 99.9-100) for survival and had 100% negative predictive value (95% CI 99.9-100) for death. Under the ALS TOR clinical prediction rule, 30% of patients would be pronounced in the field. The BLS TOR clinical prediction rule, was 100% sensitive (95% CI 99.9, 100), had 100% negative predictive value (95% CI 99.9-100) and the field pronouncement rate was 48%.
Cardiac arrest patients may be considered for prehospital ALS TOR when there is no ROSC prior to transport, no shock delivered, no bystander CPR and the arrest was not witnessed by bystanders or EMS. A single EMS termination clinical prediction rule for all levels of providers would be optimal for EMS systems to implement. Prospective evaluation of the ALS TOR clinical prediction rule in the hands of ALS providers will be required before implementation.
主要目标是为高级生命支持急救人员(ALS)推导一种新的复苏终止(TOR)临床预测规则,并测量其宣告率和诊断测试特征。次要目标包括测量先前推导并发表的基础生命支持复苏终止(BLS TOR)临床预测规则[莫里森LJ、维森廷LM、基斯A等。院外心脏骤停复苏终止规则的验证。《新英格兰医学杂志》2006年;355(5):478 - 87]在同一组患者中的测试特征,以便进行比较。
对参与OPALS研究的农村和城市急救医疗服务(EMS)系统中接受ALS治疗的成年心脏骤停患者进行二次数据分析(数据从第三阶段提取)。一项关于基础生命支持复苏终止(BLS TOR)临床预测规则的先前研究提出,如果患者在转运前无自主循环恢复(ROSC);未给予电击;EMS人员未目睹心脏骤停,则终止复苏[莫里森LJ、维森廷LM、基斯A等。院外心脏骤停复苏终止规则的验证。《新英格兰医学杂志》2006年;355(5):478 - 87]。使用多变量逻辑回归来检验这些变量、其他乌斯坦变量与出院存活这一主要结局之间的关系。在此推导队列中测量ALS TOR和BLS TOR模型的诊断测试特征。
纳入4673例心脏骤停患者;3098例(66%)为男性,平均(标准差)年龄69岁(15岁);239例(5.1%;95%置信区间4.5 - 5.8)存活至出院;3841例患者无ROSC(82%),其中仅3例存活(0.08%;95%置信区间0.02,0.23)。与存活相关的最终ALS TOR模型包括:ROSC(比值比260.9;95%置信区间96.3,706.7)、旁观者目睹(比值比2.0;95%置信区间1.3,3.1)、旁观者心肺复苏(比值比2.8;95%置信区间1.9,4.1)、EMS目睹(比值比12.3;95%置信区间7.1,21.3)以及转运前电击(比值比6.4;95%置信区间4.1,10.1)。基于这些变量的新的ALS TOR临床预测规则对存活的敏感性为100%(95%置信区间99.9 - 100),对死亡的阴性预测值为100%(95%置信区间99.9 - 100)。根据ALS TOR临床预测规则,30%的患者将在现场宣告死亡。BLS TOR临床预测规则的敏感性为100%(95%置信区间99.9,100),阴性预测值为100%(95%置信区间99.9 - 100),现场宣告率为48%。
对于在转运前无ROSC、未给予电击、无旁观者心肺复苏且旁观者或EMS未目睹心脏骤停的心脏骤停患者,可考虑在院前进行ALS TOR。对于EMS系统而言,为所有级别的急救人员制定单一的EMS终止临床预测规则将是最佳选择。在实施之前,需要对ALS急救人员手中的ALS TOR临床预测规则进行前瞻性评估。